26 July 2013
The Government of Kaluga Region, the Administrative Board of the City of Kaluga and NovaMedica pharmaceutical company (a subsidiary of RUSNANO and Domain Associates) have signed an agreement on the execution of an investment project to build a new pharmaceutical plant in the region.
The document was signed by Anatoly Artamonov, Governor of Kaluga Region, Nikolay Polezhaev, Mayor of the City of Kaluga, Nikolay Milkis, General Director of the Kaluga Region Development Corporation, and Vladimir Gurdus, General Director of D-Pharma, which is managing the NovaMedica project.
The new plant will be built under a joint venture between Domain Associates LLC, one of the leading American venture capital funds, which specializes in pharmaceuticals, and RUSNANO, a Russian government-owned investment company.
PrintVaccination against the plague using a Russian drug is currently being carried out in Mongolia
24 July 2024
24 July 2024
Russia will conduct an experiment to block the supply of low-quality products to hospitals
23 July 2024
With seventh person seemingly cured of HIV, signs of hope for a broader cure
23 July 2024